Wave Life Sciences sets Aug. 7 completion for Delaware redomiciliation

• Wave Life Sciences set Aug. 7, 2026 as the expected completion date for its redomiciliation to the US.
• The corporate reorganization shifts the group’s parent company from Singapore to a Delaware corporation.
• The Singapore High Court approved the scheme of arrangement on July 14, 2026.
• The move is expected to take effect after the close of trading on Aug. 7, 2026.
• Wave plans to file a series of SEC forms after market close on the effective date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wave Life Sciences Ltd. published the original content used to generate this news brief on August 05, 2026, and is solely responsible for the information contained therein.